US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nuo Therapeutics, Inc.

1.73

+0.14118.87%

Volume:100.00

Turnover:173.11

Market Cap:83.23M

PE:-33.54

High:1.73

Open:1.73

Low:1.73

Close:1.59

52wk High:3.23

52wk Low:1.00

Shares:48.08M

Float Shares:22.86M

Volume Ratio:0.04

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0516

EPS(LYR):-0.0293

ROE:-1032.50%

ROA:-87.97%

PB:-198.35

PE(LYR):-59.18

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Nuo Therapeutics, Inc.

Exchange:

OTCQB

Establishment Date:

1998

Employees:

9

Office Location:

8285 El Rio,Suite 190,Houston,Texas,United States

Website:

http://www.nuot.com

Zip Code:

77054

Phone:

Fax:

- -

Introduction:

Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AURX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AURX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AURX\",,,,,undefined,":{"symbol":"AURX","market":"US","secType":"STK","nameCN":"Nuo Therapeutics, Inc.","latestPrice":1.7311,"timestamp":1769806800000,"preClose":1.59,"halted":0,"volume":100,"delay":15,"changeRate":0.08874213836477987,"floatShares":22864200,"shares":48077700,"eps":-0.051611,"marketStatus":"Market Closed","change":0.1411,"latestTime":"01-30 16:00:00 EST Delay","open":1.7311,"high":1.7311,"low":1.7311,"amount":173.11,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.051611,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770022800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":1.59,"volumeRatio":0.040456345800551},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AURX\",,,,,undefined,":{"symbol":"AURX","floatShares":22864200,"roa":"-87.97%","roe":"-1032.50%","lyrEps":-0.029253,"volumeRatio":0.040456345800551,"shares":48077700,"dividePrice":0,"high":1.7311,"amplitude":0,"preClose":1.59,"low":1.7311,"week52Low":1,"pbRate":"-198.35","psRate":"31.87","week52High":3.23,"institutionHeld":0,"latestPrice":1.7311,"eps":-0.051611,"divideRate":0,"volume":100,"delay":15,"ttmEps":-0.051611,"open":1.7311,"prevYearClose":1.97,"prevWeekClose":1.57,"prevMonthClose":1.7311,"prevQuarterClose":1.97,"fiveDayClose":1.57,"twentyDayClose":1.97,"sixtyDayClose":2.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AURX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-08-12","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-05-15","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-04-19","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713499200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-20","symbol":"AURX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1700456400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AURX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AURX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1765861200000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":415042,"yearFounded":1998,"employeeNum":9,"address":"8285 El Rio,Suite 190,Houston,Texas,United States","zipCode":"77054","officePhone":"346 396 4770"},"stockCompanyDetail":{"websiteUrl":"http://www.nuot.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.5},{"period":"6month","weight":-0.4737},{"period":"1year","weight":1},{"period":"ytd","weight":1.5}],"description":"Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.","exchange":"OTCQB","name":"Nuo Therapeutics, Inc.","nameEN":"Nuo Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AURX\",market:\"US\",,,undefined,":null}}